LS Investment Advisors, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 208 filers reported holding HAEMONETICS CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LS Investment Advisors, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2021$236,000
-30.2%
2,127
-25.2%
0.01%
-27.8%
Q4 2020$338,000
+36.3%
2,8440.0%0.02%
+28.6%
Q3 2020$248,000
-2.7%
2,8440.0%0.01%
-12.5%
Q2 2020$255,000
-5.9%
2,844
+4.8%
0.02%
-20.0%
Q1 2020$271,000
-13.1%
2,7150.0%0.02%
+17.6%
Q4 2019$312,000
-21.0%
2,715
-13.3%
0.02%
-26.1%
Q3 2019$395,000
+6.2%
3,131
+1.2%
0.02%
+4.5%
Q2 2019$372,000
+27.0%
3,095
-7.7%
0.02%
+22.2%
Q1 2019$293,000
-14.6%
3,355
-2.1%
0.02%
-25.0%
Q4 2018$343,000
-2.6%
3,428
+11.5%
0.02%
+20.0%
Q3 2018$352,000
+23.5%
3,074
-3.2%
0.02%
+17.6%
Q2 2018$285,000
+115.9%
3,174
+75.8%
0.02%
+112.5%
Q1 2018$132,000
+33.3%
1,805
+5.7%
0.01%
+33.3%
Q4 2017$99,000
+5.3%
1,707
-18.2%
0.01%0.0%
Q3 2017$94,000
+19.0%
2,087
+4.1%
0.01%
+20.0%
Q2 2017$79,000
-2.5%
2,0040.0%0.01%0.0%
Q1 2017$81,000
-11.0%
2,004
-11.2%
0.01%
-16.7%
Q4 2016$91,000
+16.7%
2,257
+5.1%
0.01%0.0%
Q3 2016$78,000
+25.8%
2,1480.0%0.01%
+50.0%
Q2 2016$62,000
-10.1%
2,148
+8.8%
0.00%
-20.0%
Q1 2016$69,000
+13.1%
1,974
+4.0%
0.01%0.0%
Q4 2015$61,0000.0%1,8980.0%0.01%0.0%
Q3 2015$61,000
-24.7%
1,898
-3.1%
0.01%
-16.7%
Q2 2015$81,0001,9580.01%
Other shareholders
HAEMONETICS CORP shareholders Q3 2017
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders